Clinical Trials Directory

Trials / Completed

CompletedNCT00190060

Study of The Effects of Testosterone in Frail Elderly Men

Study of The Effects of Testosterone on Muscle Function, Physical Performance, Body Composition and Quality of Life in Frail Elderly Men

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
262 (actual)
Sponsor
Manchester University NHS Foundation Trust · Other Government
Sex
Male
Age
65 Years
Healthy volunteers
Accepted

Summary

The study aims to determine the effects of testosterone on muscle function, mobility, activities of daily living and overall quality of life

Detailed description

Ageing-associated loss of muscle mass and strength is a major cause of physical frailty, disability, morbidity and dependency in the elderly. This is associated with increased falls, fractures, loss of mobility, restricted activities of daily living and increased utilisation of healthcare resources. It is well known that serum testosterone levels fall with advancing age and this may be an important cause for muscle wasting and weakness (sarcopenia). Testosterone replacement increases muscle mass and improves muscle strength in young hypogonadal men. In relatively healthy elderly men, some short-term studies have also shown that testosterone can improve muscle strength. The potential beneficial effects of testosterone supplementation on muscle strength and functional capacity of frail elderly men has so far not been studies and forms the basis of this research. We hypothesise that testosterone supplementation is an effective, safe and economic anabolic intervention in frail elderly men with low circulating testosterone.

Conditions

Interventions

TypeNameDescription
DRUGTransdermal testosterone gel (Testogel 1% )Transdermal testosterone gel (Testogel 1% ), 50 mg/d for 6 months
DRUGMatched transdermal placebo gelMatched transdermal placebo gel, 50mg/d for 6 months

Timeline

Start date
2004-10-01
Primary completion
2008-12-31
Completion
2008-12-31
First posted
2005-09-19
Last updated
2018-08-03

Locations

1 site across 1 country: United Kingdom

Source: ClinicalTrials.gov record NCT00190060. Inclusion in this directory is not an endorsement.